Media Coverage

CoLucid raises $7.5M for novel migraine headache drug

Link: http://www.medcitynews.com/2011/08/colucid-raises-7-5m-for-novel-migraine-headache-drug/?edition=dealflow

Back to List

Lasmiditan

image of lasmiditan structure

Lasmiditan is a member of a novel chemical class called "ditans." Lasmiditan penetrates the central nervous system (CNS) and selectively targets 5-HT1F receptors expressed in the trigeminal nerve pathway.

Learn More About Lasmiditan